EGFR and colorectal carcinoma: We demonstrated that the AMI-1 treatment could mimick the phenotypes caused by the PRMT1-Δ on colony formation, migration capabilities, and expression of TNS4 and EGFR of CRC cells in a dose-dependent manner (Additional file 1: Fig. S8a-d).